Douglas E. Giordano is Director at Cerevel Therapeutics Holdings, Inc. (CERE). They have made 1 open-market trade across 1 company since 2013, most recently 2026-06-17.
CIK 0001431552
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
1 open-market purchase totalling $130K since 2013, never a sale. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| ZTS | BUY | 2013-02-06 | 2013-02-08 | $26.00 | $130K | -7.9% | +0.7% | +0.7% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.